Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Baxter
Novartis
UBS
Harvard Business School
Accenture
Healthtrust
Merck
Moodys
Citi

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,110,605

« Back to Dashboard

Summary for Patent: 5,110,605
Title: Calcium polycarbophil-alginate controlled release composition and method
Abstract:A polymeric complex composition comprising a reaction complex formed by the interaction of a polycarbophil component with alginic acid or a salt thereof, said interaction being performed in the presence of a divalent cation and in the presence of an active agent selected from the group consisting of medicinal agents and cosmetic agents. There is also described a method of controlled release treatment comprising the steps of providing such a polymeric complex and an effective amount of an active agent selected from the group consisting of medicinal agents and cosmetic agents contained within said complex, and contacting an area of skin or mucous membrane to be treated with said composition for a sufficient period of time allow a therapeutically effective amount of said active agent to be released from the complex.
Inventor(s): Acharya; Ramesh N. (Lake Forest, IL)
Assignee: Oramed, Inc. (Mundelein, IL)
Application Number:07/570,340
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 5,110,605

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,110,605

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 137404 ➤ Sign Up
Australia 8444291 ➤ Sign Up
Germany 69119217 ➤ Sign Up
Denmark 0497956 ➤ Sign Up
European Patent Office 0497956 ➤ Sign Up
Spain 2088500 ➤ Sign Up
Greece 3020502 ➤ Sign Up
Japan 3064417 ➤ Sign Up
Japan H05502894 ➤ Sign Up
World Intellectual Property Organization (WIPO) 9203124 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Boehringer Ingelheim
Medtronic
Chinese Patent Office
UBS
US Department of Justice
Cipla
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot